Is there relief for rheumatoid arthritis? RA is a chronic inflammatory disease in which the immune system attacks the joints and other body parts. According to research or other evidence, the following self-care steps may be helpful:
These recommendations are not comprehensive and are not intended to replace the advice of your doctor or pharmacist. Continue reading the full rheumatoid arthritis article for more in-depth, fully-referenced information on medicines, vitamins, herbs, and dietary and lifestyle changes that may be helpful.
Rheumatoid arthritis (RA) is a chronic inflammatory disease in which the immune system attacks the joints and sometimes other parts of the body. The cause of RA remains unknown.
Product ratings for rheumatoid arthritis
|Science Ratings||Nutritional Supplements||Herbs|
Tripterygium wilfordii Hook F
Cajeput oil (topical)
Eucalyptus oil (topical)
Fir needle oil (topical)
Pine needle oil (topical)
Rosemary oil (topical)
|See also: Homeopathic Remedies for Rheumatoid Arthritis|
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support and/or minimal health benefit.
The most common symptom of RA is joint pain and morning joint stiffness. Several joints on both sides of the body are usually affected, especially those of the hands, wrists, knees, and feet. Affected joints may feel warm or appear swollen. People with RA may have other symptoms, including weakness, fatigue, weight loss, and, occasionally, fever.
Feeding a high-fat diet to animals who are susceptible to autoimmune disease has increased the severity of RA.1 People with RA have been reported to eat more fat, particularly animal fat, than those without RA.2 In short-term studies, diets completely free of fat have helped people with RA.3 Since at least some dietary fat is essential for humans, though, the significance of this finding is not clear.
Strictly vegetarian diets that are also very low in fat have been reported to reduce RA symptoms.4 5 In the 1950s through the 1970s, Max Warmbrand, a naturopathic doctor, used a very low-fat diet to treat people with RA. He recommended a diet free of meat, dairy, chemicals, sugar, eggs, and processed foods.6 A short-term (ten weeks) study employing a similar approach failed to produce beneficial effects.7 Long before publication of that negative report, however, Dr. Warmbrand had claimed that his diet took at least six months to achieve noticeable results. In one trial lasting 14 weeks—still significantly less than six months—a pure vegetarian, gluten-free (no wheat, rye, or barley) diet was gradually changed to permit dairy, leading to improvement in both symptoms and objective laboratory measures of disease.8 The extent to which a low-fat vegetarian diet (or one low in animal fat) would help people with RA remains unclear.
Preliminary evidence suggests that consumption of olive oil, rich in oleic acid, may decrease the risk of developing RA.9 One trial in which people with RA received either fish oil or olive oil, found that olive oil capsules providing 6.8 grams of oleic acid per day for 24 weeks produced modest clinical improvement and beneficial changes in immune function. However, as there was no placebo group in that trial, the possibility of a placebo effect cannot be ruled out.10
Fasting has been shown to improve both signs and symptoms of RA, but most people have relapsed after the returning to a standard diet.11 12 When fasting was followed by a 12-month vegetarian diet, however, the benefits of fasting appeared to persist.13 14 It is not known why the combination of these dietary programs (i.e., fasting followed by a vegetarian diet) might be helpful, and the clinical trial that investigated this combination15 has been criticized both for its design and interpretation.16 17 18
Food sensitivities develop when pieces of intact protein in food are able to cross through the intestinal barrier. Many patients with RA have been noted to have increased intestinal permeability, especially when experiencing symptoms,19 and RA has been linked to allergies and food sensitivities.20 In many people, RA worsens when they eat foods to which they are allergic or sensitive and improves by avoiding these foods.21 22 23 24 In one study, the vast majority of RA patients had elevated levels of antibodies to milk, wheat, or both, suggesting a high incidence of allergy to these substances.25 English researchers have reported that one-third of people with RA may be able to control their disease completely through allergy elimination.26 Identification and elimination of symptom-triggering foods should be done with the help of a physician.
Drinking four or more cups of coffee per day has been associated with an increased risk of developing rheumatoid arthritis in preliminary research.27
Although exercise may initially increase pain, gentle exercises help people with RA.28 29 Women with RA taking low-dose steroid therapy can safely participate in a weight-bearing exercise program with many positive effects on physical function, activity and fitness levels, and bone mineral density, and with no aggravation of disease activity.30 Many doctors recommend swimming, stretching, or walking to people with RA.
Joint replacement surgery is sometimes used in cases of severe deformity or disability.
People with RA have been reported to have an impaired antioxidant system, making them more susceptible to free radical damage.31 Vitamin E is an important antioxidant, protecting many tissues, including joints, against oxidative damage. Low vitamin E levels in the joint fluid of people with RA have been reported.32 In a double-blind trial, approximately 1,800 IU per day of vitamin E was found to reduce pain from RA.33 Two other double-blind trials (using similar high levels of vitamin E) reported that vitamin E had approximately the same effectiveness in reducing symptoms of RA as anti-inflammatory drugs.34 35 In other double-blind trials, 600 IU of vitamin E taken twice daily was significantly more effective than placebo in reducing RA, although laboratory measures of inflammation remained unchanged.36 37
Oils containing the omega-6 fatty acid gamma linolenic acid (GLA)—borage oil,38 39 40 black currant seed oil,41 and evening primrose oil (EPO)42 43 —have been reported to be effective in the treatment for people with RA. Although the best effects have been reported with use of borage oil, that may be because more GLA was used in borage oil trials (1.1–2.8 grams per day) compared with trials using black currant seed oil or EPO. The results with EPO have been mixed and confusing, possibly because the placebo used in those trials (olive oil) may have anti-inflammatory activity. In a double-blind trial, positive results were seen when EPO was used in combination with fish oil.44 GLA appears to be effective because it is converted in part to prostaglandin E1, a hormone-like substance known to have anti-inflammatory activity.
Many double-blind trials have proven that omega-3 fatty acids in fish oil, called EPA and DHA, partially relieve symptoms of RA.45 46 47 48 49 50 The effect results from the anti-inflammatory activity of fish oil.51 Many doctors recommend 3 grams per day of EPA and DHA, an amount commonly found in 10 grams of fish oil. Positive results can take three months to become evident. In contrast, a double-blind trial found flaxseed oil (source of another form of omega-3 fatty acid) not to be effective for RA patients.52
Cetyl myristoleate (CMO) has been proposed to act as a joint “lubricant” and anti-inflammatory agent. In a double-blind trial, people with various types of arthritis that had failed to respond to nonsteroidal anti-inflammatory drugs received either CMO (540 mg per day orally for 30 days) or a placebo.53 These people also applied CMO or placebo topically, according to their perceived need. Sixty-four percent of those receiving CMO improved, compared with 14% of those receiving placebo. More research is needed to determine whether CMO has a legitimate place in the treatment options offered RA patients.
The use of dimethyl sulfoxide (DMSO) for therapeutic applications is controversial in part because some claims made by advocates appear to extend beyond current scientific evidence, and in part because topical use greatly increases the absorption of any substance that happens to be on the skin, including molecules that are toxic to the body. Nonetheless, there is some preliminary evidence that when applied to the skin, it has anti-inflammatory properties and alleviates pain, such as that associated with RA.54 55 DMSO appears to reduce pain by inhibiting the transmission of pain messages by nerves.56 It comes in different strengths and degrees of purity, and certain precautions must be taken when applying DMSO. For these reasons, DMSO should be used only under the supervision of a doctor.
Research suggests that people with RA may be partially deficient in pantothenic acid (vitamin B5).57 In one placebo-controlled trial, those with RA had less morning stiffness, disability, and pain when they took 2,000 mg of pantothenic acid per day for two months.58
Supplementation with New Zealand green-lipped mussel (Perna canaliculus) significantly improved RA symptoms in 68% of participants in a double-blind trial.59 Other studies have been carried out, some of which have confirmed these findings, while others have not.60 61 62 63 64 In a recent double-blind trial, use of green-lipped mussel as a lipid extract (210 mg per day) or a freeze-dried powder (1,150 mg per day) for three months led to a decrease in joint tenderness and morning stiffness, and to better overall function.65 However, members of the Australian Rheumatism Association have reported side effects, such as stomach upset, gout, and skin rashes, occurring in people taking certain New Zealand green-lipped mussel extracts. One case of hepatitis has been reported in association with the use of a New Zealand green-lipped mussel extract.66
Deficient zinc levels have been reported in people with RA.67 Some trials have found that zinc reduced RA symptoms,68 but others have not.69 70 Some suggest that zinc might only help those who are zinc-deficient,71 and, although there is no universally accepted test for zinc deficiency, some doctors check white-blood-cell zinc levels.
People with RA have been found to have lower selenium levels than healthy people.72 73 One74 of two double-blind trials using at least 200 mcg of selenium per day for three to six months found that selenium supplementation led to a significant reduction in pain and joint inflammation in RA patients, but the other reported no beneficial effect.75 More controlled trials are needed to determine whether selenium reduces symptoms in people with RA.
Copper acts as an anti-inflammatory agent needed to activate superoxide dismutase (SOD), an enzyme that protects joints from inflammation. People with RA tend toward copper deficiency76 and copper supplementation has been shown to increase SOD levels in humans.77 The Journal of the American Medical Association quoted one researcher as saying that while “Regular aspirin had 6% the anti-inflammatory activity of [cortisone] . . . copper [when added to aspirin] had 130% the activity [of cortisone].”78
Several copper compounds have been used successfully in treating people with RA,79 and a controlled trial using copper bracelets reported surprisingly effective results compared with the effect of placebo bracelets.80 Under certain circumstances, however, copper can increase inflammation in rheumatoid joints.81 Moreover, the form of copper most consistently reported to be effective, copper aspirinate (a combination of copper and aspirin), is not readily available. Nonetheless, some doctors suggest a trial of 1–3 mg of copper per day for at least several months.
Boron supplementation at 3–9 mg per day may be beneficial, particularly in treating people with juvenile RA, according to very preliminary research.82 The benefit of using boron to treat people with RA remains unproven.
D-phenylalanine has been used with mixed results to treat chronic pain, including pain caused by RA.83 No research has evaluated the effectiveness of DL-phenylalanine, a related supplement, in treating people with RA. The effect of either form of phenylalanine in the treatment of people with RA remains unproven.
Many years ago, two researchers reported that some individuals with RA had inadequate stomach acid.84 Hydrochloric acid, called HCl by chemists, is known to help break down protein in the stomach before the protein can be absorbed in the intestines. Allergies generally occur when inadequately broken down protein is absorbed from the intestines. Therefore, some doctors believe that when stomach acid is low, supplementing with betaine HCl can reduce food-allergy reactions by helping to break down protein before it is absorbed. In theory such supplementation might help some people with RA, but no research has investigated whether betaine HCl actually reduces symptoms of RA.
Supplementation with betaine HCl should be limited to people who have a proven deficit in stomach acid production. Of doctors who prescribe betaine HCl, the amount used varies with the size of the meal and with the amount of protein ingested. Although typical amounts recommended by doctors range from 600 to 2,400 mg of betaine HCl per meal, use of betaine HCl needs to be monitored by a healthcare practitioner and tailored to the needs of the individual.
Bromelain has significant anti-inflammatory activity. Many years ago in a preliminary trial, people with RA who were given bromelain supplements experienced a decrease in joint swelling and improvement in joint mobility.85 The amount of bromelain used in that trial was 20–40 mg, three or four times per day, in the form of enteric-coated tablets. The authors provided no information about the strength of activity in the bromelain supplements that were used. (Today, better quality bromelain supplements are listed in gelatin-dissolving units [GDU] or in milk-clotting units [MCU].) Enteric-coating protects bromelain from exposure to stomach acid. Most commercially available bromelain products today are not enteric-coated.
Propolis is the resinous substance collected by bees from the leaf buds and bark of trees, especially poplar and conifer trees. Anti-inflammatory effects from topical application of propolis extract have been noted in one animal study,86 and a preliminary controlled trial found that patients with RA treated with topical propolis extract (amount and duration not noted) had greater improvements in symptoms compared to placebo.87
Boswellia is an herb used in Ayurvedic medicine (the traditional medicine of India) to treat arthritis. Boswellia has reduced symptoms of RA in most reports.88 While some double-blind trials89 using boswellia have produced positive results, some equivocal results90 and negative findings have also been reported.91 In some trials where boswellia has appeared ineffective, though, patients have been allowed to continue use of nonsteroidal anti-inflammatory drugs (NSAIDs). Such use of NSAIDs can confound experimental results, because boswellia and NSAIDs work in a similar fashion to reduce inflammation. Some doctors suggest using 400–800 mg of gum resin extract in capsules or tablets three times per day.
A cream containing small amounts of capsaicin, a substance found in cayenne pepper, can help relieve pain when rubbed onto arthritic joints, according to the results of a double-blind trial.92 Capsaicin achieves this effect by depleting nerves of a pain-mediating neurotransmitter called substance P. Although application of capsaicin cream initially causes a burning feeling, the burning lessens with each application and disappears for most people in a few days. Creams containing 0.025–0.075% of capsaicin are available and may be applied to the affected joints three to five times a day. A doctor should supervise this treatment.
Devil’s claw has anti-inflammatory and analgesic actions. Several open and double-blind trials have been conducted on the anti-arthritic effects of devil’s claw.93 The results of these trials have been mixed, so it is unclear whether devil’s claw lives up to its reputation in traditional herbal medicine as a remedy for people with RA. A typical amount used is 800 mg of encapsulated extracts three times per day or powder in the amount of 4.5–10 grams per day.
Turmeric is a yellow spice often used to make curry dishes. The active constituent, curcumin, is a potent anti-inflammatory compound that protects the body against free radical damage.94 A double-blind trial found curcumin to be an effective anti-inflammatory agent in RA patients.95 The amount of curcumin usually used is 400 mg three times per day.
Ginger is another Ayurvedic herb used to treat people with arthritis. A small number of case studies suggest that taking 6–50 grams of fresh or powdered ginger per day may reduce the symptoms of RA.96 A combination formula containing ginger, turmeric, boswellia, and ashwagandha has been shown in a double-blind trial to be slightly more effective than placebo for RA;97 the amounts of herbs used in this trial are not provided by the investigators.
The historic practice of applying nettle topically (with the intent of causing stings to relieve arthritis) has been assessed by a questionnaire study.98 The nettle stings were reported to be safe except for causing a sometimes painful, sometimes numbing rash lasting 6 to 24 hours. Further studies are required to determine whether this practice is therapeutically effective.
Yucca, a traditional remedy, is a desert plant that contains soap-like components known as saponins. Yucca tea (7 or 8 grams of the root simmered in a pint of water for 15 minutes) is often drunk for symptom relief three to five times per day. The effects of yucca in the treatment of people with RA has not been studied.
Burdock root has been used historically both internally and externally to treat painful joints. Its use in the treatment of people with RA remains unproven.
Although willow is slow acting as a pain reliever, the effect is thought to last longer than the effect of willow’s synthetic cousin, aspirin. One double-blind trial found that willow bark combined with guaiac, sarsaparilla, black cohosh, and poplar (each tablet contained 100 mg of willow bark, 40 mg of guaiac, 35 mg of black cohosh, 25 mg of sarsaparilla, and 17 mg of poplar) relieved pain due to RA better than placebo over a two-month period.99 The exact amount of the herbal combination used in the trial is not given, however, and patients were allowed to continue their other pain medications. Clinical trials on willow alone for RA are lacking. Some experts suggest that willow may be taken one to four weeks before results are noted.100
Topical applications of several botanical oils are approved by the German government for relieving symptoms of RA.101 These include primarily cajeput (Melaleuca leucodendra) oil, camphor oil, eucalyptus oil, fir (Abies alba and Picea abies) needle oil, pine (Pinus spp.) needle oil, and rosemary oil. A few drops of oil or more can be applied to painful joints several times a day as needed. Most of these topical applications are based on historical use and are lacking modern clinical trials to support their effectiveness in treating RA.
Preliminary studies conducted in India with the herb picrorhiza show a benefit for people with RA.102 Currently, this therapeutic effect remains weakly supported and therefore unproven.
Southwestern Native American and Hispanic herbalists have long recommended topical use of chaparral on joints affected by RA. The anti-inflammatory effects of chaparral found in test tube research suggests this practice might have value, though clinical trials have not yet investigated chaparral’s usefulness in people with RA. Chaparral should not be used internally for this purpose.
Cat’s claw has been used traditionally for RA, but no human trials have investigated this practice.
Meadowsweet was used historically for a wide variety of conditions, including treating rheumatic complaints of the joints and muscles.103
In a preliminary trial, an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F, in the amount of 360 to 570 mg per day for 16 weeks, produced improvement in symptoms and laboratory tests in eight of nine patients with rheumatoid arthritis. However, one patient developed high blood pressure during the trial.104 In a double-blind trial, an extract of this herb, given in the amount of 360 mg per day for 20 weeks was significantly more effective than a placebo at reducing disease activity.105 A lower amount (160 mg/day) was also more effective than the placebo, but the difference was not statistically significant. No serious side effects were reported.
The role of manipulation in managing RA has received little study. In one small controlled trial,106 patients with RA were found to have more tenderness at certain body locations compared to healthy people. Six minutes of gentle spinal manipulation decreased this tenderness temporarily in the spinal areas but not in areas around the knees or ankles. The effect of manipulation on the symptoms or progression of RA has not been investigated.
1. Levy JA, Ibrahim AB, Shirai T, et al. Dietary fat affects immune response, production of antiviral factors, and immune complex disease in NZP/NZW mice. Proc Natl Acad Sci 1982;79:1974–8.
2. Jacobsson I, Lindgarde F, Manthorpe R, et al. Correlation of fatty acid composition of adipose tissue lipids and serum phosphatidylcholine and serum concentrations of micronutrients with disease duration in rheumatoid arthritis. Ann Rheum Dis 1990;49:901–5.
3. Lucas CP, Power L. Dietary fat aggravates active rheumatoid arthritis. Clin Res 1981;29:754A [abstract].
4. Skoldstam L. Fasting and vegan diet in rheumatoid arthritis. Scand J Rheumatol 1987;15:219–21.
5. Nenonen M, Helve T, Hanninen O. Effects of uncooked vegan food—“living food”—on rheumatoid arthritis, a three month controlled and randomised study. Am J Clin Nutr 1992;56:762 [abstract #48].
6. Warmbrand M. How Thousands of My Arthritis Patients Regained Their Health. New York: Arco Publishing, 1974.
7. Panush RS, Carter RL, Katz P, et al. Diet therapy for rheumatoid arthritis. Arthrit Rheum 1983;26:462–71.
8. KjeldsenKragh J, Haugen M, Borchgrevink CF, et al. Controlled trial of fasting and oneyear vegetarian diet in rheumatoid arthritis. Lancet 1991;338:899–902.
9. Linos A, Kaklamani VG, Koukmantaki Y, et al. Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables. Am J Clin Nutr 1999;70:1077–82.
10. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 1990;33:810–20.
11. Hafström I, Ringertz B, Gyllenhammar H, et al. Effects of fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis. Arthritis Rheum 1988;31:585–92.
12. Skoldstam L, Magnusson KE. Fasting, intestinal permeability, and rheumatoid arthritis. Rheum Dis Clin North Am 1991;17:363–71 [review].
13. KjeldsenKragh J, Haugen M, Borchgrevink CF, et al. Controlled trial of fasting and oneyear vegetarian diet in rheumatoid arthritis. Lancet 1991;338:899–902.
14. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Forre O. Vegetarian diet for patients with rheumatoid arthritis-status: two years after introduction of the diet. Clin Rheumatol 1994;13:475–82.
15. KjeldsenKragh J, Haugen M, Borchgrevink CF, et al. Controlled trial of fasting and oneyear vegetarian diet in rheumatoid arthritis. Lancet 1991;338:899–902.
16. Seignalet J. Diet, fasting, and rheumatoid arthritis. Lancet 1992;339:68–9 [letter].
17. Abuzakouk M, O’Farrelly C. Diet, fasting, and rheumatoid arthritis. Lancet 1992;339:68 [letter].
18. Panayi GS. Diet, fasting, and rheumatoid arthritis. Lancet 1992;339:69 [letter].
19. Cordain L, Toohey L, Smith MJ, Hickey MS. Modulation of immune function by dietary lectins in rheumatoid arthritis. Br J Nutr 2000;83(3):207–17.
20. Zeller M. Rheumatoid arthritis—food allergy as a factor. Ann Allerg 1949;7:200–5,239.
21. Darlington LG, Ramsey NW, Mansfield JR. Placebocontrolled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet 1986;i:236–8.
22. Beri D, Malaviya AN, Shandilya R, Singh RR. Effect of dietary restrictions on disease activity in rheumatoid arthritis. Ann Rheum Dis 1988;47:69–72.
23. Panush RS. Possible role of food sensitivity in arthritis. Ann Allerg 1988;61(part 2):31–5.
24. Taylor MR. Food allergy as an etiological factor in arthropathies: a survey. J Internat Acad Prev Med 1983;8:28–38 [review].
25. O’Farrelly C, Price R, McGillivray AJ, Fernandes L. IgA rheumatoid factor and IgG dietary protein antibodies are associated in rheumatoid arthritis. Immunol Invest 1989;18(6):753–64.
26. Darlington LG, Ramsey NW. Diets for rheumatoid arthritis. Lancet 1991;338:1209 [letter].
27. Heliövaara M, Aho K, Knekt P, et al. Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis 2000;59:631–5.
28. Kay DR, Webel RB, Drisinger TE, et al. Aerobic exercise improves performance in arthritis patients. Clin Res 1985;33:919A [abstract].
29. Harkcom TM, Lampman RM, Banwell BF, Castor CW. Therapeutic value of graded aerobic exercise training in rheumatoid arthritis. Arthrit Rheum 1985;28:32–8.
30. Westby MD, Wade JP, Rangno KK, Berkowitz J. A randomized controlled trial to evaluate the effectiveness of an exercise program in women with rheumatoid arthritis taking low dose prednisone. J Rheumatol 2000;27:1674–80.
31. Ozturk HS, Cimen MY, Cimen OB, et al. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999;19:35–7.
32. Fairburn K, Grootveld M, Ward RJ, et al. Alpha-tocopherol, lipids and lipoproteins in knee-joint synovial fluid and serum from patients with inflammatory joint disease. Clin Sci 1992;83:657–64.
33. Scherak O, Kolarz G. Vitamin E and rheumatoid arthritis. Arthrit Rheum 1991;34:1205–6 [letter].
34. Wittenborg A, Petersen G, Lorkowski G, Brabant T. Effectiveness of vitamin E in comparison with diclofenac sodium in treatment of patients with chronic polyarthritis. Z Rheumatol 1998;57:215–21 [in German].
35. Kolarz G, Scherak O, El Shohoumi M, Blankenhorn G. High dose vitamin E for chronic arthritis. Akt Rheumatol 1990;15:233–7 [in German].
36. Edmonds SE, Winyard PG, Guo R, et al. Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double-blind trial. Ann Rheum Dis 1997;56:649–55.
37. Miehle W. Vitamin E in active arthroses and chronic polyarthritis. What is the value of alpha-tocopherol in therapy? Fortschr Med 1997;115:39–42.
38. Pullman-Mooar S, Laposata M, Lem D, et al. Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid. Arthritis Rheum 1990;33:1526–33.
39. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med 1993;119:867–73.
40. Zurier RB, Rossetti RG, Jacobson EW, et al. Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis Rheum 1996;39:1808–17.
41. Leventahn LJ, Boyce EG, Zuerier RB. Treatment of rheumatoid arthritis with black currant seed oil. Br J Rheumatol 1994;33:847–52.
42. Brzeski M, Madhok R, Capell HA. Evening primrose oil in patients with rheumatoid arthritis and sideeffects of nonsteroidal antiinflammatory drugs. Brit J Rheumatol 1991;30:370–2.
43. Jantti J, Seppala E, Vapaatalo H, Isomaki H. Evening primrose oil and olive oil in treatment of rheumatoid arthritis. Clin Rheumatol 1989;8:238–44.
44. Belch JJ, Ansell D, Madhok R, et al. Effects of altering dietary essential fatty acids on requirements for nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis 1988;47:96–104.
45. Kremer JM, Jubiz W, Michalek A, et al. Fishoil fatty acid supplementation in active rheumatoid arthritis. Ann Int Med 1987;106(4):497–503.
46. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arthrit Rheum 1990;33(6):810–20.
47. Geusens P, Wouters C, Nijs J, et al. Longterm effect of omega3 fatty acid supplementation in active rheumatoid arthritis. Arthrit Rheum 1994;37:824–9.
48. Van der Tempel H, Tulleken JE, Limburg PC, et al. Effects of fish oil supplementation in rheumatoid arthritis. Ann Rheum Dis 1990;49:76–80.
49. Cleland LG, French JK, Betts WH, et al. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 1988;15(10):1471–5.
50. Kremer JM, Lawrence DA, Petrillow GF, et al. Effects of highdose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Arthritis Rheum 1995;38:1107–14.
51. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985;312(19):1217–24.
52. Nordstrom DC, Honkanen VE, Nasu Y, et al. Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed. Rheumatol Int 1995;14:231–4.
53. Siemandi H. The effect of cis-9- cetyl myristoleate (CMO) and adjunctive therapy on arthritis and auto-immune disease: a randomized trial. Townsend Letter for Doctors and Patients. 1997;Aug/Sept:58–63.
54. American Medical Association. Dimethyl sulfoxide. Controversy and Current Status—1981. JAMA 1982;248:1369–71.
55. Jimenez RAH, Willkens RF. Dimethyl sulfoxide: A perspective of its use in rheumatic diseases. J Lab Clin Med 1982;100:489–500.
56. Jacob SW, Wood DC. Dimethyl sulfoxide (DMSO). Toxicology, pharmacology, and clinical experience. Am J Surg 1967;114:414–26.
57. Barton-Wright EC, Elliott WA. The pantothenic acid metabolism of rheumatoid arthritis. Lancet 1963;ii:862–3.
58. General Practitioner Research Group. Calcium pantothenate in arthritic conditions. Practitioner 1980;224:208–11.
59. Gibson RG, Gibson SLM, Conway V, Chappell D. Perna canaliculus in the treatment of arthritis. Practitioner 1980;224:955–660.
60. Audeval B, Bouchacourt P. Etude controle en double aveugle contra placebo de l’extrait de moule Perna canaliculus dans las gonarthrose. Gazette Medicale 1986;38:111–6.
61. Huskisson EC, Scott J, Bryans R. Seatone is ineffective in rheumatoid arthritis. BMJ 1981;282:1358–9.
62. Caughey DE, Grigor RR, Caughey EB, et al. Perna canaliculus in the treatment of rheumatoid arthritis. Eur J Rheumatol Inflamm 1983;6:197–200.
63. Larkin JG, Capell HA, Sturrock RD. Seatone in rheumatoid arthritis: a six-month placebo controlled study. Ann Rheum Dis 1985;44:199–201.
64. Highton TC, McArthur AW. Pilot study on the effect of New Zealand green mussel on rheumatoid arthritis. N Z Med J 1975;81:261–2.
65. Gibson SLM, Gibson RG. The treatment of arthritis with a lipid extract of Perna canaliculus: a randomized trial. Comp Ther Med 1998;6:122–6.
66. Brooks PM. Side effects from Seatone. Med J Aust 1980;2:158 [letter].
67. Aaseth J, Munthe E, Forre O, Steinnes E. Trace elements in serum and urine of patients with rheumatoid arthritis. Scand J Rheumatol 1978;7:237–40.
68. Simkin PA. Oral zinc sulphate in rheumatoid arthritis. Lancet 1976;ii:539–42.
69. Peretz A, Neve J, Jeghers O, Pelen F. Zinc distribution in blood components, inflammatory status, and clinical indexes of disease activity during zinc supplementation in inflammatory rheumatic diseases. Am J Clin Nutr 1993;57:690–4.
70. Job C, Menkes CJ, de Gery A, et al. Zinc sulphate in the treatment of rheumatoid arthritis. Arthrit Rheum 1980;23:1408.
71. Simkin PA. Treatment of rheumatoid arthritis with oral zinc sulfate. Agents Actions 1981;8(suppl):587–96.
72. Tarp U, Overvad K, Hansen JC, Thorling EB. Low selenium level in severe rheumatoid arthritis. Scand J Rheumatol 1985;14:97–101.
73. Aaseth J, Munthe E, Forre O, Steinnes E. Trace elements in serum and urine of patients with rheumatoid arthritis. Scand J Rheumatol 1978;7:237–40.
74. Peretz A, Neve J, Duchateau J, Famaey JP. Adjuvant treatment of recent onset rheumatoid arthritis by selenium supplementation: preliminary observations. Br J Rheumatol 1992;31:281–2 [letter].
75. Tarp U, Overvad K, Thorling EB, et al. Selenium treatment in rheumatoid arthritis. Scand J Rheumatol 1985;14:364–8.
76. DiSilvestro RA, Marten J, Skehan M. Effects of copper supplementation on ceruloplasmin and copperzinc superoxide dismutase in freeliving rheumatoid arthritis patients. J Am Coll Nutr 1992;11:177–80.
77. Jones AA, DiSilvestro RA, Coleman M, Wagner TL. Copper supplementation of adult men: effects on blood copper enzyme activities and indicators of cardiovascular disease risk. Metabolism 1997;46:1380–3.
78. Medical News. Copper boosts activity of anti-inflammatory drugs. JAMA 1974;229:1268–9.
79. Sorenson JRJ. Copper complexes—a unique class of antiarthritic drugs. Progress Med Chem 1978;15:211–60 [review].
80. Walker WR, Keats DM. An investigation of the therapeutic value of the ‘copper bracelet’—dermal assimilation of copper in arthritic/rheumatoid conditions. Agents Actions 1976;6:454–9.
81. Blake DR, Lunec J. Copper, iron, free radicals and arthritis. Brit J Rheumatol 1985;24:123–7 [editorial].
82. Newnham RE. Arthritis or skeletal fluorosis and boron. Int Clin Nutr Rev 1991;11:68–70 [letter].
83. Balagot RC, Ehrenpreis S, Kubota K, et al. Analgesia in mice and humans by D-phenylalanine: Relation to inhibition of enkephalin degradation and enkephalin levels. Adv Pain Res Ther 1983;5:289–93.
84. Hartung EF, Steinbroker O. Gastric acidity in chronic arthritis. Ann Intern Med 1935;9:252.
85. Cohen A, Goldman J. Bromelain therapy in rheumatoid arthritis. Pennsylvania Med J 1964;67:27–30.
86. Park EH, Kahng JH. Suppressive effects of propolis in rat adjuvant arthritis. Arch Pharm Res 1999;22:554–8.
87. Siro B, Szelekovszky S, Lakatos B, et al. Local treatment of rheumatic diseases with propolis compounds. Orv Hetil 1996;137:1365–70 [in Hungarian].
88. Etzel R. Special extract of Boswellia serrata in the treatment of rheumatoid arthritis. Phytomed 1996;3:91–4 [review].
89. Singh GB, Singh S, Bani S. New phytotherapeutic agent for the treatment of arthritis and allied disorders with novel mode of action. 4th International Congress on Phytotherapy, Munich, Germany, Sep 10–3, 1992.
90. Chopra A, Lavin P, Patwardhan B, Chitre D. Randomized double blind trial of an Ayurvedic plant derived formulation for treatment of rheumatoid arthritis. J Rheumatol 2000;27:1365–72.
91. Sander O, Herborn G, Rau R. Is H15 (resin extract of Boswellia serrata, “incense”) a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study. Z Rheumatol 1998 ;57:11–6 [in German].
92. Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with topical capsaicin: A double-blind trial. Clin Ther 1991;13:383–95.
93. Bone K. The story of devil’s claw: Is it an herbal antirheumatic? Nutrition and Healing 1998;October:3,4,8 [review].
94. Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis with a herbomineral formulation: A double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 1991;33:91–5.
95. Deodhar SD, Sethi R, Srimal RC. Preliminary studies on antirheumatic activity of curcumin (diferuloyl methane). Ind J Med Res 1980;71:632–4.
96. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypoth 1992;39:342–8.
97. Chopra A, Lavin P, Patwardhan B, Chitre D. Randomized double blind trial of an Ayurvedic plant derived formulation for treatment of rheumatoid arthritis. J Rheumatol 2000;27:1365–72.
98. Randall C, Meethan K, Randall H, Dobbs F. Nettle sting of Urtica dioica for joint pain—an exploratory study of this complementary therapy. Compl Ther Med 1999;7:126–31.
99. Mills SY, Jacoby RK, Chacksfield M, Willoughby M. Effect of a proprietary herbal medicine on the relief of chronic arthritic pain: A double-blind study. Br J Rheum 1996;35:874–8.
100. Upton R, Petrone C, eds. Willow bark (Salix spp.) monograph. Santa Cruz, CA: American Herbal Pharmacopoeia, 1999.
101. Blumenthal M, Busse WR, Goldberg A, et al., eds. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council and Boston: Integrative Medicine Communications, 1998, 430–1.
102. Langer JG, Gupta OP, Atal CK. Clinical trials on Picrorhiza kurroa. Ind J Pharmacol 1981;13:98–103 [review].
103. Zeylstra H. Filipendila ulmaria. Br J Phytotherapy 1998;5:8–12.
104. Tao X, Cush JJ, Garret M, Lipsky PE. A phase I study of ethyl acetate extract of the Chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol 2001;28:2160–7.
105. Tao X, Younger J, Fan FZ, et al. Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: A double-blind, placebo-controlled study. Arthritis Rheum 2002;46:1735–43.
106. Dhondt W, Willaeys T, Verbruggen LA, et al. Pain threshold in patients with rheumatoid arthritis and effect on manual oscillations. Scand J Rheumatol 1999;28:88–93.
Copyright © 2007 Healthnotes, Inc. All rights reserved. www.healthnotes.com
The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires September 2008.